Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric mastocytosis.

K Hartmann1, D D Metcalfe

  • 1Department of Dermatology, University of Cologne, Germany.

Hematology/Oncology Clinics of North America
|July 26, 2000
PubMed
Summary
This summary is machine-generated.

Pediatric mastocytosis, often transient, differs from adult forms. Genetic findings reveal distinct c-kit mutations in children versus adults, impacting mast cell growth factor receptor pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of alpha-gal sensitivity in patients with a diagnosis of idiopathic anaphylaxis.

Allergy·2017
Same author

Proposed diagnostic criteria and classification of basophilic leukemias and related disorders.

Leukemia·2017
Same author

Development and validation of the mastocytosis quality of life questionnaire: MC-QoL.

Allergy·2016
Same author

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis.

Leukemia·2015
Same author

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.

Allergy·2014
Same author

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Area of Science:

  • Pediatric Hematology
  • Dermatology
  • Human Genetics

Background:

  • Pediatric mastocytosis involves diverse skin lesions and symptoms due to elevated mast cells.
  • Unlike adults, pediatric mastocytosis typically follows a transient clinical course.
  • This suggests potential differences in the underlying pathogenetic mechanisms between pediatric and adult mastocytosis.

Purpose of the Study:

  • To investigate the distinct pathogenetic mechanisms of pediatric mastocytosis compared to adult forms.
  • To explore the role of genetic mutations, particularly in the c-kit gene, in disease development.

Main Methods:

  • Analysis of genetic findings in pediatric and adult mastocytosis patients.
  • Comparison of c-kit gene mutation status between different age groups.

Related Experiment Videos

  • Clinical observation of disease course and symptom presentation.

    • Main Results:

    • Adult mastocytosis commonly features activating mutations in the c-kit growth factor receptor.
    • Most pediatric cases lack these activating mutations; some exhibit inactivating c-kit mutations.
    • Activating c-kit mutations are primarily observed in children with progressive mastocytosis.

    Conclusions:

    • Genetic differences, specifically in c-kit mutations, underpin distinct pathogenetic mechanisms in pediatric and adult mastocytosis.
    • Current management focuses on symptomatic relief with antihistamines and trigger avoidance.
    • Further research into causal treatments for mastocytosis is warranted.